Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Teladoc Health Inc (TDOC) vs Wells Fargo & Co (WFC) Price & Performance

Teladoc Health IncTrade
Wells Fargo & CoTrade

Price performance (Past 24H)

Key statistics

Teladoc Health Inc vs Wells Fargo & Co — how do they compare? Teladoc Health Inc trades at $5.54 (market cap $1.01B), while Wells Fargo & Co trades at $81.8 (market cap $248.06B). The key difference: Wells Fargo & Co is far larger — about 245.6× Teladoc Health Inc's market cap, and Wells Fargo & Co pays a 2.44% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Teladoc Health Inc for 39 Days and Wells Fargo & Co for 87 Days on average.

TDOCWFC
Market Cap
$1.01B$248.06B
Volume
4,668,47716,615,741
Sector
HealthFinancials
52-Week High
$9.72$96.40
52-Week Low
$4.47$73.42
Typical Hold Time
39 Days87 Days
Enterprise Value
$1.27B$503.91B
Dividend Yield
—2.44%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Teladoc Health Inc

Teladoc Health (TDOC) trades at $5.56, down 3.64% on the day, reflecting persistent bearish technical signals and negative earnings. The stock shows weak profitability with a net income margin of -7.13% and negative ROE, though valuation ratios like P/S of 0.4 and EV/EBITDA of 5.89 appear low. Recent news includes a CFO transition and ongoing investor investigations, adding to uncertainty.

The outlook remains challenging due to consecutive net losses and competitive pressures, but the consensus price target of $8.83 suggests potential upside if operational improvements materialize. Key risks include sustained unprofitability, high debt levels, and weak sentiment, requiring careful monitoring of cost management and revenue stabilization efforts.

Wells Fargo & Co

Wells Fargo (WFC) trades at $80.26, down 1.53% today, with a bearish technical signal despite recent earnings beat in Q2 2026. The company shows strong fundamentals with a P/E of 11.92, net income margin of 25.97%, and a recent credit rating upgrade to 'A-' by S&P (Zacks Investment Research, 2026-10-01). Revenue growth is steady, reaching $83.70B in 2025, with a consensus price target of $99.13 suggesting upside potential.

The stock presents a value opportunity with attractive valuation metrics and improving profitability, but faces risks from volatile cash flows and regulatory changes in bank stress tests. Analyst sentiment is mixed with 46.66% buy ratings, while technical indicators signal near-term caution. Upside hinges on Q3 2026 earnings meeting expectations of $1.85 EPS.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TDOC

No sentiment data available yet.

WFC
100% Buy0% Sell
Avg holding period · 87 Days

Top news

Latest headlines on both assets

About Teladoc Health Inc

Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.

Read more on TDOC →

About Wells Fargo & Co

Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.

Read more on WFC →